FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Bioavailability/Bioequivalence Data Integrity Guide

FDA makes available a draft guidance entitled Data Integrity for In Vivo Bioavailability and Bioequivalence Studies.

latest-news-card-1
Biologics

Mixed Data on Colon Cancer Vaccine

Gritstone Bio reports mixed data from an ongoing Phase 2 portion of a Phase 2/3 study evaluating Granite, a personalized neoantigen cancer vaccine for...

Human Drugs

Characterize Obesity as a Chronic Disease: Lilly

Eli Lilly says any revision of an FDA guidance on weight management drugs should incorporate a modern scientific characterization of obesity as a chro...

latest-news-card-1
Medical Devices

FDA Increasing Scrutiny of CooperSurgical IUD: Report

A report by Spotlight on America suggests FDA is increasing scrutiny over CooperSurgical and its manufacturing facility in North Tonawanda, NY, where ...

latest-news-card-1
Human Drugs

Guidance on Case Safety Report eSubmissions

FDA posts a guidance entitled FDA Regional Implementation Guide for E2B(R3) Electronic Transmission of Individual Case Safety Reports for Drug and Bio...

latest-news-card-1
Federal Register

Guide on Oxymetazoline HCl ANDAs

Federal Register notice: FDA makes available a draft guidance entitled Draft Guidance on Oxymetazoline Hydrochloride.

latest-news-card-1
Human Drugs

FDA Developing New Drug Safety Tools: Dal Pan

CDER Office of Surveillance and Epidemiology director Gerald J. Dal Pan says FDA is developing new tools to help identify drug postmarket safety issue...

latest-news-card-1
Medical Devices

Baxter Novum IQ Large Volume Pump Cleared

FDA clears a Baxter International 510(k) clearance for its Novum IQ large volume infusion pump with Dose IQ safety software.

latest-news-card-1
Human Drugs

AstraZenecas Voydeya OKd for Hemolysis

FDA approves AstraZenecas Voydeya (danicopan) as an add-on therapy to Ultomiris (ravulizumab) or Soliris (eculizumab) for treating extravascular hemol...

latest-news-card-1
Biologics

Eisai sBLA for Monthly Alzheimers Maintenance

Eisai files a supplemental BLA for monthly Leqembi (lecanemab-irmb) intravenous maintenance dosing in Alzheimers disease patients.